UA66787C2 - A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds - Google Patents

A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds

Info

Publication number
UA66787C2
UA66787C2 UA99105491A UA99105491A UA66787C2 UA 66787 C2 UA66787 C2 UA 66787C2 UA 99105491 A UA99105491 A UA 99105491A UA 99105491 A UA99105491 A UA 99105491A UA 66787 C2 UA66787 C2 UA 66787C2
Authority
UA
Ukraine
Prior art keywords
preparation
methylpiperazine
ethoxyphenyl
pyrazolo
pyrimidine
Prior art date
Application number
UA99105491A
Other languages
English (en)
Inventor
Peter James Dann
Philippe Charles Levett
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA66787(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of UA66787C2 publication Critical patent/UA66787C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UA99105491A 1998-10-12 1999-10-08 A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds UA66787C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
UA66787C2 true UA66787C2 (en) 2004-06-15

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99105491A UA66787C2 (en) 1998-10-12 1999-10-08 A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds

Country Status (48)

Country Link
US (3) US6207829B1 (cs)
EP (1) EP0994115B1 (cs)
JP (1) JP3721021B2 (cs)
KR (1) KR100380954B1 (cs)
CN (2) CN1473831A (cs)
AP (1) AP1233A (cs)
AR (1) AR019244A1 (cs)
AT (1) ATE290003T1 (cs)
AU (1) AU756463B2 (cs)
BG (1) BG63205B1 (cs)
BR (1) BR9905092A (cs)
CA (1) CA2285733C (cs)
CO (1) CO5150214A1 (cs)
CR (1) CR6118A (cs)
CU (1) CU22928A3 (cs)
CZ (1) CZ296816B6 (cs)
DE (1) DE69923906T2 (cs)
DK (1) DK0994115T3 (cs)
DZ (1) DZ2912A1 (cs)
EA (1) EA003774B1 (cs)
EE (1) EE04192B1 (cs)
EG (1) EG22630A (cs)
ES (1) ES2237049T3 (cs)
GB (1) GB9822238D0 (cs)
GE (1) GEP20022700B (cs)
GT (1) GT199900172A (cs)
HR (1) HRP990318B1 (cs)
HU (1) HU226162B1 (cs)
ID (1) ID23351A (cs)
IL (11) IL152924A (cs)
IS (1) IS1951B (cs)
MA (1) MA25007A1 (cs)
MY (1) MY124620A (cs)
NO (1) NO313700B1 (cs)
OA (1) OA11165A (cs)
PE (1) PE20001086A1 (cs)
PL (1) PL198150B1 (cs)
PT (1) PT994115E (cs)
RS (1) RS49762B (cs)
SG (1) SG118060A1 (cs)
SI (1) SI0994115T1 (cs)
SK (1) SK285215B6 (cs)
TN (1) TNSN99189A1 (cs)
TR (1) TR199902541A2 (cs)
TW (1) TW589314B (cs)
UA (1) UA66787C2 (cs)
UY (1) UY25750A1 (cs)
ZA (1) ZA996412B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
TR200401983T4 (tr) * 2000-06-22 2004-09-21 Pfizer Inc. Pirazolpirimidinonların preparasyon işlemi
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
CA2469075C (en) * 2001-12-20 2011-09-13 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as prostaglandin modulators
AU2002367023A1 (en) * 2001-12-21 2003-07-30 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
EP1605752B1 (en) * 2003-03-27 2011-09-14 Cytokinetics, Inc. Sulfonamides for the treatment of congestive heart failure, their compositions and uses.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
ID22834A (id) * 1997-04-25 1999-12-09 Pfizer Pirazolopimidinona untuk kelainan seksual

Also Published As

Publication number Publication date
UY25750A1 (es) 2001-08-27
IS1951B (is) 2004-10-13
EA199900822A3 (ru) 2000-08-28
KR20000028987A (ko) 2000-05-25
AR019244A1 (es) 2001-12-26
NO994943D0 (no) 1999-10-11
TNSN99189A1 (fr) 2005-11-10
DE69923906D1 (de) 2005-04-07
AP1233A (en) 2003-12-18
US20030069422A1 (en) 2003-04-10
BG103794A (en) 2000-09-29
YU48999A (sh) 2002-06-19
IL152927A (en) 2004-06-01
CZ296816B6 (cs) 2006-06-14
BR9905092A (pt) 2000-08-08
BG63205B1 (bg) 2001-06-29
TW589314B (en) 2004-06-01
SK138599A3 (en) 2000-05-16
ID23351A (id) 2000-04-13
HUP9903469A3 (en) 2000-10-30
PT994115E (pt) 2005-06-30
ATE290003T1 (de) 2005-03-15
PE20001086A1 (es) 2000-10-18
EG22630A (en) 2003-05-31
IS5209A (is) 2000-04-13
IL152923A (en) 2004-02-08
IL152928A0 (en) 2003-06-24
EE04192B1 (et) 2003-12-15
HU226162B1 (en) 2008-05-28
NO313700B1 (no) 2002-11-18
MA25007A1 (fr) 2000-07-01
ZA996412B (en) 2001-04-11
US6207829B1 (en) 2001-03-27
IL152926A0 (en) 2003-06-24
IL152924A (en) 2004-02-19
EP0994115A2 (en) 2000-04-19
GEP20022700B (en) 2002-05-27
EA199900822A2 (ru) 2000-04-24
EA003774B1 (ru) 2003-08-28
IL132273A0 (en) 2001-03-19
CN1473831A (zh) 2004-02-11
SG118060A1 (en) 2006-01-27
CN1255497A (zh) 2000-06-07
AU756463B2 (en) 2003-01-16
PL335959A1 (en) 2000-04-25
TR199902541A2 (xx) 2000-07-21
CZ353299A3 (cs) 2000-05-17
CA2285733C (en) 2004-08-24
CN1207295C (zh) 2005-06-22
DK0994115T3 (da) 2005-06-20
HUP9903469A2 (hu) 2000-08-28
HK1027559A1 (en) 2001-01-19
DZ2912A1 (fr) 2004-03-01
CR6118A (es) 2005-09-16
PL198150B1 (pl) 2008-05-30
OA11165A (en) 2003-04-22
CU22928A3 (es) 2004-02-20
IL152924A0 (en) 2003-06-24
HRP990318B1 (en) 2004-06-30
AU5358199A (en) 2000-04-13
DE69923906T2 (de) 2006-04-06
GB9822238D0 (en) 1998-12-09
GT199900172A (es) 2001-03-28
IL152926A (en) 2004-02-19
AP9901672A0 (en) 1999-12-31
EP0994115A3 (en) 2000-05-24
JP2000119273A (ja) 2000-04-25
CO5150214A1 (es) 2002-04-29
EP0994115B1 (en) 2005-03-02
RS49762B (sr) 2008-04-04
EE9900507A (et) 2000-06-15
MY124620A (en) 2006-06-30
HRP990318A2 (en) 2000-06-30
IL152923A0 (en) 2003-06-24
IL152928A (en) 2007-07-04
KR100380954B1 (ko) 2003-04-21
IL152927A0 (en) 2003-06-24
HU9903469D0 (en) 1999-12-28
NO994943L (no) 2000-04-13
SI0994115T1 (cs) 2005-08-31
CA2285733A1 (en) 2000-04-12
SK285215B6 (sk) 2006-09-07
JP3721021B2 (ja) 2005-11-30
US20010009962A1 (en) 2001-07-26
ES2237049T3 (es) 2005-07-16
IL132273A (en) 2004-06-20

Similar Documents

Publication Publication Date Title
UA66787C2 (en) A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds
CA2207694A1 (en) Process for preparing sildenafil
IL73258A0 (en) 7-aminoazolo(1,5-a)pyrimidines,their preparation and their use as fungicides
MY109731A (en) Process for preparing aryl piperazinyl-heterocyclic compounds.
CA2095587A1 (en) Process for preparing aryl piperazinyl-hetero-cyclic compounds
PL338181A1 (en) Novel chemical compounds
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
MX9708696A (es) Cefalosporinas antibacterianas.
BG103778A (en) Process for preparing pyrazole derivatives
CA2294609A1 (en) Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ATE294779T1 (de) Arylpiperidinopropanol und arylpiperazinopropanol derivate und die selbe enthaltende pharmazeutika
PL328789A1 (en) Novel heterocyclic compounds, method of obtaining them, their application in production of a pharmaceutic agent and pharmaceutic agent obtained thereby
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
TR199900321T2 (xx) N-(1-nbutil - 4 - piperidil)metil) -3,4-dihidro -2H- (1,3) oksazino (3.2A) indol-10- Karboksamit haz�rlama prosesi ve prosesteki tuzlar ve ara �r�nler.
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
MY130190A (en) Method for the preparation of 4-halo-2'- nitrobutyrophenone compounds
NZ513551A (en) Novel process for preparing alendronic acid
HK1046406A1 (zh) 用於增強認知的吡唑[1，5-d][1，2，4]三氮烯
AU3350195A (en) Bicyclic carboxamides as 5-HT-1A antagonists
AU7206898A (en) Method for producing 1,3-di-substituted 2-nitroguanidines
CA2284501A1 (en) Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
MY127737A (en) Novel process for the preparation of pyrazolopyrimidinones